Access Robust Datasets, Successfully Harness AI, & Streamline Integrated Evidence Planning to Drive Efficiency, Support Regulatory & HTA Decision-Making, & Accelerate Speed to Market
Real-World Evidence has become a critical driver of competitive advantage across pharma and biotech, enabling faster drug development, stronger regulatory submissions, and improved market access outcomes. As FDA and payer expectations evolve, organizations must now deliver decision-grade evidence that is credible, scalable, and aligned across the development lifecycle.
The 14th IMPACCT Real-World Evidence Summit is the only dedicated industry forum uniting leaders across RWE, real-world data, evidence generation, HEOR, and market access to tackle the most pressing challenges in the field. From selecting regulatory-ready datasets to embedding AI and advanced analytics into workflows, this summit focuses on how to consistently translate data into actionable decisions.
Join leading experts fromconnected with 140+ industry pioneers from AstraZeneca, Pfizer, Novartis, Boehringer Ingelheim and more to build integrated evidence strategies, accelerate timelines, and maximize the ROI of real-world evidence investment.
The IMPACCT Summit is a premier forum for engaging with leading experts in real-world evidence across clinical development, regulatory affairs, medical affairs, and pharmacovigilance. Presentations showcase cutting-edge advances in RWE methodology and application, while the format facilitates extensive networking and knowledge exchange among attendees!
Executive Director & Head of Epidemiology & Real-World Science, Alexion Pharmaceuticals
This conference, in particular, is specially designed to address data quality and linkages, understand evolving expectations from the FDA, and maximize value of data purchases, which is in line with our team goals and expectations to have the right data at the right time
Real-World Data Strategy, Emerging Therapies Lead, Novo Nordisk
IMPACCT provides a comprehensive opportunity to discuss the current developments within RWE
Lead Research Analyst for Medical Policy & Health Technology Evaluation, Independence Blue Cross
View The 2025 Event Guide to See What You Missed
- Explore 20+ real-world case studies across clinical development, regulatory, and market access
- Discover how leading pharma are embedding AI into RWE workflows
- Benchmark integrated evidence planning strategies across the lifecycle
- Identify solutions to improve data quality, access, and regulatory acceptance
- Share insights with cross-functional RWE, HEOR, and data leaders
2025 Expert Speaker Faculty:
2026 Partners
Attending Companies Included
Explore Related Events
Explore the Agenda
Discover how to design, implement, and scale decision-grade RWE across clinical and access teams
Partner With Us
Position your organization at the forefront of RWE innovation and connect with decision-makers investing in data and analytics
Join Industry Experts
Be part of the leading strategic RWE forum driving regulatory, clinical, and access decisions